Evaluation of major depressive disorder in patients receiving chronic treatment with topical timolol

Ophthalmologica

Volumn 226, Issue 3, 2011, Pages 157-160

  Bali, Shveta Jindal ^a   Parmar, Twinkle ^a   Arora, Vishal ^a   Ichhpujani, Parul ^c   Sagar, Rajesh ^b   Dada, Tanuj ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^c GOVERNMENT MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

Blockers; Depression; Glaucoma; Mood disorder

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PROSTAGLANDIN DERIVATIVE; TIMOLOL;

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; EVALUATION; FEMALE; GENDER; GLAUCOMA; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE;

ADMINISTRATION, TOPICAL; ADRENERGIC BETA-ANTAGONISTS; AGED; ANTIHYPERTENSIVE AGENTS; CASE-CONTROL STUDIES; CHRONIC DISEASE; DEPRESSIVE DISORDER; FEMALE; GLAUCOMA, ANGLE-CLOSURE; GLAUCOMA, OPEN-ANGLE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PREVALENCE; PROSTAGLANDINS F, SYNTHETIC; QUESTIONNAIRES; TIMOLOL;

EID: 81155161870     PISSN: 00303755     EISSN: 14230267     Source Type: Journal    
DOI: 10.1159/000328585     Document Type: Article

References (17)

1. Skalicky S, Goldberg I: Depression and quality of life in patients with glaucoma: a crosssectional analysis using the Geriatric Depression Scale-15, assessment of function related to vision, and the Glaucoma Quality of Life-15. J Glaucoma 2008; 17: 546-551.
2. Mabuchi F, Yoshimura K, Kashiwagi K, Shioe K, Yamagata Z, Kanba S, Iijima H, Tsukahara S: High prevalence of anxiety and depression in patients with primary open-angle glaucoma. J Glaucoma 2008; 17: 552-557.
3. Vander Zanden JA, Valuck RJ, Bunch CL, Perlman JI, Anderson C, Wortman GI: Systemic adverse effects of ophthalmic betablockers. Ann Pharmacother 2001; 35: 1633-1637. (Pubitemid 34027467)
4. Lama PJ: Systemic adverse effects of beta-adrenergic blockers: an evidence-based assessment. Am J Ophthalmol 2002; 134: 749-760. (Pubitemid 35300397)
5. Kaiserman I, Kaiserman N, Elhayany A, Vinker S: Topical beta-blockers are not associated with an increased risk of treatment for depression. Ophthalmology 2006; 113: 1077-1080. (Pubitemid 43947251)
6. Ko DT, Hebert PR, Coffey CS, Sedrakyan A, Curtis JP, Krumholz HM: Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA 2002; 288: 351-357. (Pubitemid 34761614)
7. Patten SB, Lavorato DH: Medication use and major depressive syndrome in a community population. Compr Psychiatry 2001; 42: 124-131. (Pubitemid 32207247)
8. Ried LD, McFarland BH, Johnson RE, Brody KK: Beta-blockers and depression: the more the murkier? Ann Pharmacother 1998; 32: 699-708.
9. Bright RA, Everitt DE: Beta-blockers and depression. Evidence against an association. JAMA 1992; 267: 1783-1787.
10. Parker T, May PA, Maviglia MA, Petrakis S, Sunde S, Gloyd SV: PRIME-MD: its utility in detecting mental disorders in American Indians. Int J Psychiatry Med 1997; 27: 107-128. (Pubitemid 27407504)
11. Spitzer RL, Williams JB, Kroenke K, Hornyak R, McMurray J: Validity and utility of the PRIME-MD Patient Health Questionnaire in assessment of 3000 obstetric-gynecologic patients: the PRIME-MD Patient Health Questionnaire Obstetrics-Gynecology Study. Am J Obstet Gynecol 2000; 183: 759-769.
12. Lynch MG, Whitson JT, Brown RH, Nguyen H, Drake MM: Topical beta-blocker therapy and central nervous system side effects. A preliminary study comparing betaxolol and timolol. Arch Ophthalmol 1988; 106: 908-911.
13. Duch S, Duch C, Pasto L, Ferrer P: Changes in depressive status associated with topical beta-blockers. Int Ophthalmol 1992; 16: 331-335.
14. Schweitzer I, Maguire K, Tuckwell V: Antiglaucoma medication and clinical depression. Aust N Z J Psychiatry 2001; 35: 569-571. (Pubitemid 32982604)
15. Wilson MR, Coleman AL, Yu F, Fong Sasaki I, Bing EG, Kim MH: Depression in patients with glaucoma as measured by self-report surveys. Ophthalmology 2002; 109: 1018-1022. (Pubitemid 34465240)
16. Kochhar PH, Rajadhyaksha SS, Suvarna VR: Translation and validation of brief patient health questionnaire against DSM IV as a tool to diagnose major depressive disorder in Indian patients. J Postgrad Med 2007; 53: 102-107.
17. Zimmerman TJ, Kooner KS, Kandarakis AS, Ziegler LP: Improving the therapeutic index of topically applied ocular drugs. Arch Ophthalmol 1984; 102: 551